Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1

摘要

Triazole derivatives of structural formula I are selective inhibitors of the 11beta-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM.